Challenges in Identifying Candidate Amplification Targets in Human Cancers: Chromosome 8q21 as a Case Study

Genes and Cancer

Volumn 3, Issue 2, 2012, Pages 87-101

  Byrne, Jennifer A ^a,b   Chen, Yuyan ^a   Martin la Rotta, Nancy ^a,b   Peters, Gregory B ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

array CGH; chromosome 8q21; gene amplification; SNP profiling

Indexed keywords

BREAST CANCER; CANCER GENETICS; CASE STUDY; CHROMOSOME 8Q; CHROMOSOME 8Q21; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; MUTATOR GENE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANCRIPTION ELONGATOR FACOTR B POLYPEPTIDE 1 GENE; TUMOR PROTEIN D52 GENE; WW DOMAIN CONTAINING E3 UBIQUITIN PROTEIN LIGASE 1 GENE;

EID: 84869796075     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601912456287     Document Type: Review

References (67)

1. Harris TJ,McCormick F.The molecular pathology of cancer.Nat Rev Clin Oncol. 2010;7:251-65.
2. Santarius T,Shipley J,Brewer D,Stratton MR,Cooper CS.A census of amplified and overexpressed human cancer genes.Nat Rev Cancer. 2010;10:59-64.
3. Wood LD,Parsons DW,Jones S, et al.The genomic landscapes of human breast and colorectal cancers.Science. 2007;318:1108-13.
4. Leary RJ,Lin JC,Cummins J, et al.Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers.Proc Natl Acad Sci U S A. 2008;105:16224-9.
5. Balleine RL,Fejzo MS,Sathasivam P,Basset P,Clarke CL,Byrne JA.The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma.Genes Chromosomes Cancer. 2000;29:48-57.
6. Porkka K,Saramäki O,Tanner M,Visakorpi T.Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays.Lab Invest. 2002;82:629-37.
7. Chen C,Sun X,Guo P, et al.Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer.Oncogene. 2007;26:2386-94.
8. Chen C,Zhou Z,Ross JS,Zhou W,Dong JT.The amplified WWP1 gene is a potential molecular target in breast cancer.Int J Cancer. 2007;12:180-7.
9. Weir BA,Woo MS,Getz G, et al.Characterizing the cancer genome in lung adenocarcinoma.Nature. 2007;450:893-8.
10. Kallioniemi A,Kallioniemi O-P,Piper J, et al.Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.Proc Natl Acad Sci U S A. 1994;91:2156-60.
11. Isola JJ,Kallioniemi OP,Chu LW, et al.Genetic aberrations detected by comparative genomic hybridization predict outcome in node negative breast cancer.Am J Pathol. 1995;147:905-11.
12. Ried T,Just KE,Holtgreve-Grez H, et al.Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas.Cancer Res. 1995;55:5415-23.
13. Nishizaki T,DeVries S,Chew K, et al.Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization.Genes Chromosomes Cancer. 1997;19:267-72.
14. Tirkkonen M,Tanner M,Karhu R,Kallioniemi A,Isola J,Kallioniemi O-P.Molecular cytogenetics of primary breast cancer by CGH.Genes Chromosomes Cancer. 1998;21:177-84.
15. Cher ML,MacGrogan D,Bookstein R,Brown JA,Jenkins RB,Jensen RH.Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer.Genes Chromosomes Cancer. 1994;11:153-62.
16. Cher ML,Bova GS,Moore DH, et al.Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization.Cancer Res. 1996;56:3091-102.
17. Muleris M,Almeida A,Gerbault-Seureau M,Malfoy B,Dutrillaux B.Detection of DNA amplification in 17 primary breast carcinomas with homogenously staining regions by a modified comparative genomic hybridization technique.Genes Chromosomes Cancer. 1994;10:160-70.
18. Courjal F,Theillet C.Comparative genomic hybridization of breast tumors with predetermined profiles of DNA amplification.Cancer Res. 1997;57:4368-77.
19. Tarkkanen M,Karhu R,Kallioniemi A, et al.Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization.Cancer Res. 1995;55:1334-8.
20. Suehiro Y,Sakamoto M,Umayahara K, et al.Genetic aberrations detected by comparative genomic hybridization in ovarian clear cell adenocarcinomas.Oncology. 2000;59:50-66.
21. Partheen K,Levan K,Osterberg L,Helou K,Horvath G.Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage.Genes Chromosomes Cancer. 2004;40:342-8.
22. Melchor L,Alvarez S,Honrado E, et al.The accumulation of specific amplifications characterizes two different genomic pathways of evolution of familial breast tumors.Clin Cancer Res. 2005;11:8577-84.
23. Rennstam K,Ahlstedt-Soini M,Baldetorp B, et al.Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis: a study of 305 tumors by comparative genomic hybridization.Cancer Res. 2003;63:8861-8.
24. Han W,Han MR,Kang JJ, et al.Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.BMC Cancer. 2006;6:92.
25. Jalava SE,Porkka KP,Rauhala HE, et al.TCEB1 promotes invasion of prostate cancer cells.Int J Cancer. 2009;124:95-102.
26. Shehata M,Weidenhofer J,Thamotharampillai K,Hardy JR,Byrne JA.Tumor protein D52 overexpression and gene amplification in cancers from a mosaic of microarrays.Crit Rev Oncog. 2008;14:33-55.
27. Abkevich V,Iliev D,Timms KM, et al.Computational method for estimating DNA copy numbers in normal samples, cancer cell lines, and solid tumors using array comparative genomic hybridization.J Biomed Biotechnol. 2010;2010:386870.
28. Beroukhim R,Mermel CH,Porter D, et al.The landscape of somatic copy-number alteration across human cancers.Nature. 2010;463:899-905.
29. Man TK,Lu XY,Jaeweon K, et al.Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.BMC Cancer. 2004;4:45.
30. Yao J,Weremowicz S,Feng B, et al.Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.Cancer Res. 2006;66:4065-78.
31. Kulke MH,Freed E,Chiang DY, et al.High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss.Genes Chromosomes Cancer. 2008;47:591-603.
32. Rodriguez V,Chen Y,Elkahloun A,Dutra A,Pak E,Chandrasekharappa S.Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer.Genes Chromosomes Cancer. 2007;46:694-707.
33. Chin SF,Teschendorff AE,Marioni JC, et al.High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.Genome Biol. 2007;8:R215.
34. Kim JH,Dhanasekaran SM,Mehra R, et al.Integrative analysis of genomic aberrations associated with prostate cancer progression.Cancer Res. 2007;67:8229-39.
35. Ramakrishna M,Williams LH,Boyle SE, et al.Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis.PLoS One. 2010;5:e9983.
36. Zhang Y,Martens JW,Yu JX, et al.Copy number alterations that predict metastatic capability of human breast cancer.Cancer Res. 2009;69:3795-801.
37. van Duin M,van Marion R,Vissers K, et al.High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.Genes Chromosomes Cancer. 2005;44:438-49.
38. Woo HG,Park ES,Lee JS, et al.Identification of potential driver genes in human liver carcinoma by genomewide screening.Cancer Res. 2009;69:4059-66.
39. Holcomb IN,Young JM,Coleman IM, et al.Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer.Cancer Res. 2009;69:7793-802.
40. Kao J,Salari K,Bocanegra M, et al.Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.PLoS One. 2009;4:e6146.
41. Jia D,Wei L,Guo W, et al.Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma.Hepatology. 2011;54:1227-36.
42. Marchiò C,Iravani M,Natrajan R, et al.Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast.J Pathol. 2008;215:398-410.
43. Natrajan R,Lambros MB,Rodríguez-Pinilla SM, et al.Tiling path genomic profiling of grade 3 invasive ductal breast cancers.Clin Cancer Res. 2009;15:2711-22.
44. Sayagués JM,Fontanillo C,Abad Mdel M, et al.Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays.PLoS One. 2010;5:e13752.
45. Jönsson G,Staaf J,Olsson E, et al.High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.Genes Chromosomes Cancer. 2007;46:543-58.
46. Guedj M,Marisa L,de Reynies A, et al.A refined molecular taxonomy of breast cancer.Oncogene. 2012;31:1196-206.
47. Pollack JR,Sørlie T,Perou CM, et al.Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.Proc Natl Acad Sci U S A. 2002;99:12963-8.
48. Adélaïde J,Finetti P,Bekhouche I, et al.Integrated profiling of basal and luminal breast cancers. Cancer Res. 2007;67:11565-75.
49. Paris PL,Hofer MD,Albo G, et al.Genomic profiling of hormone-naive lymph node metastases in patients with prostate cancer.Neoplasia. 2006;8:1083-9.
50. Andre F,Job B,Dessen P, et al.Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.Clin Cancer Res. 2009;15:441-51.
51. Natrajan R,Weigelt B,Mackay A, et al.An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers.Breast Cancer Res Treat. 2010;121:575-89.
52. Mattison J,Kool J,Uren AG, et al.Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach.Cancer Res. 2010;70:883-95.
53. Hyman E,Kauraniemi P,Hautaniemi S, et al.Impact of DNA amplification on gene expression patterns in breast cancer.Cancer Res. 2002;62:6240-5.
54. Staaf J,Jönsson G,Ringnér M, et al.High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.Breast Cancer Res. 2010;12:R25.
55. Madoz-Gúrpide J,Cañamero M,Sanchez L,Solano J,Alfonso P,Casal JI.A proteomics analysis of cell signaling alterations in colorectal cancer.Mol Cell Proteomics. 2007;6:2150-64.
56. Hu N,Wang C,Ng D, et al.Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China.Cancer Res. 2009;69:5908-17.
57. Li X,Mertens-Talcott SU,Zhang S,Kim K,Ball J,Safe S.MicroRNA-27a indirectly regulates estrogen receptor-a expression and hormone responsiveness in MCF-7 breast cancer cells.Endocrinology. 2010;151:2462-73.
58. Mermel CH,Schumacher SE,Hill B,Meyerson ML,Beroukhim R,Getz G.GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.Genome Biol. 2011;12:R41.
59. Iafrate AJ,Feuk L,Rivera MN, et al.Detection of large-scale variation in the human genome.Nat Genet. 2004;36:949-51.
60. de Smith AJ,Tsalenko A,Sampas N, et al.Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: implications for association studies of complex diseases.Hum Mol Genet. 2007;16:2783-94.
61. Ahn SM,Kim TH,Lee S, et al.The first Korean genome sequence and analysis: full genome sequencing for a socio-ethnic group.Genome Res. 2009;19:1622-9.
62. Pang AW,MacDonald JR,Pinto D, et al.Towards a comprehensive structural variation map of an individual human genome.Genome Biol. 2010;11:R52.
63. Schulze A,Downward J.Analysis of gene expression by microarrays: cell biologist's gold mine or minefield?.J Cell Sci. 2000;113:4151-6.
64. Diamandis EP,Hudson T,Kallioniemi O,Liu ET,López-Otín C.Cancer genomes.Clin Chem. 2010;56:1660-4.
65. Hillmer L,Yao F,Inaki K, et al.Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes.Genome Res. 2011;21:665-75.
66. Chin L,Hahn WC,Getz G,Meyerson M.Making sense of cancer genomic data.Genes Dev. 2011;25:534-55.
67. Vincent-Salomon A,Lucchesi C,Gruel N, et al.Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.Clin Cancer Res. 2008;14:1956-65.